Alternatives to Aelis Farma

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

Clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) for cancer treatment.

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

Pharmaceutical company focused on addiction treatment and mental health.

International specialty pharmaceutical company focused on central nervous system, pain management, and addiction treatments.

Pharmaceutical company developing transdermal cannabinoid therapeutics for behavioral and emotional conditions.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A global leader in clinical pharmacology and bioanalytical sciences.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Developing novel immunotherapies and diagnostics for cancer.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.